U-Chart Analysis:BrightPath Biotherapeutics Co., Ltd.:4594

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index BrightPath Biotherapeutics Co., Ltd. Go to web site 4594 Medicals 東証グロース March 1, 2000 2015.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

BrightPath Biotherapeutics Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2024年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2023年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2022年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2021年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents 1,057 1,531 2,305 3,265 3,018
Other Current AssetsHelp 124 120 391 386 310
Tangible Fixed AssetsHelp 0 0 25 48 97
Intangible Fixed AssetHelp 0 0 0 0 0
Investments and OthersHelp 49 50 50 50 49
Total AssetsHelp 1,230 1,701 2,771 3,749 3,475
Total Current LiabilitiesHelp 251 134 240 212 239
Total Long-term LiabilitiesHelp 0 0 0 0 0
Shareholder's EquityHelp 979 1,568 2,531 3,538 3,235
Total LiabilitiesHelp 1,230 1,701 2,771 3,749 3,475

BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2024年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2023年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2022年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2021年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales 0 5 15 3 11
Total Sales 0 5 15 3 11
Cost of SalesHelp 0 2 3 1 4
Other Costs and RevenueHelp 1,168 1,489 1,496 1,721 1,865
Total CostsHelp 1,168 1,491 1,500 1,722 1,869
Net RevenueHelp 0 3 12 1 7
Earnings Before TaxHelp -1,166 -1,484 -1,482 -1,717 -1,860
Net IncomeHelp -1,168 -1,486 -1,484 -1,720 -1,858
Net Income -1,168 -1,486 -1,484 -1,720 -1,858

BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2024年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2023年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2022年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2021年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help -1,157 -1,204 -1,512 -1,770 -1,784
Investing Cash Flow(ICF)Help -8 -2 -18 -36 -107
Financing Cash FlowHelp 691 432 569 2,053 9
Exchange Difference of Cash and Cash EquivalentsHelp 0 0 0 -0 0
Net Increase and Decrease in Cash and Cash Equivalentsn -474 -774 -960 247 -1,883

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

BrightPath Biotherapeutics Co., Ltd.

Company where related level is highHelp

CellSource Co., Ltd.
CanBas Co.,Ltd.
Nissui Pharmaceutical Co.,Ltd.
MIZUHO MEDY CO.,LTD.
TAIKO PHARMACEUTICAL CO.,LTD.
AnGes,Inc.
Medrx Co.,Ltd.
TAISHO PHARMACEUTICAL CO.,LTD.
JCR Pharmaceuticals Co.,Ltd.
KAINOS Laboratories,Inc.